No abstract available
Intermesoli T., Castagnetti F., Soverini S., Bussini A., Spinelli O., Gnani A., et al. (2012). Durable molecular response despite F317L and E255K mutations: Successful treatment of chronic myeloid leukemia with sequential imatinib, nilotinib and dasatinib. LEUKEMIA RESEARCH, 36(1), e10-e11 [10.1016/j.leukres.2011.09.002].
Durable molecular response despite F317L and E255K mutations: Successful treatment of chronic myeloid leukemia with sequential imatinib, nilotinib and dasatinib.
CASTAGNETTI, FAUSTO;SOVERINI, SIMONA;
2012
Abstract
No abstract availableFile in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
